» Articles » PMID: 7705958

A Stress-inducible 72-kDa Heat-shock Protein (HSP72) is Expressed on the Surface of Human Tumor Cells, but Not on Normal Cells

Overview
Journal Int J Cancer
Specialty Oncology
Date 1995 Apr 10
PMID 7705958
Citations 160
Authors
Affiliations
Soon will be listed here.
Abstract

It is suggested that members of the heat-shock protein (HSP) 70 and 90 families are involved in intracellular antigen processing and the presentation of cell-membrane-anchored antigens. We show that non-lethal heat shock (41.8 degrees C) causes comparable rates of HSP72 (about 20x) and HSP73 (about 3x) synthesis in both tumor (including human Ewing's sarcoma, ES and osteosarcoma cells, HOS58) and normal cells (including EBV-transformed B-LCL, PBL and fibroblasts derived from healthy human volunteers). However, following non-lethal heat stress and a recovery period at 37 degrees C, flow cytometric analysis with a specific MAb showed HSP72 to be expressed only on the cell surface of tumor cells. The cell-surface localization of HSP72 was confirmed by Western-blot analysis of separated membranes and by immunoprecipitation with the HSP72-specific MAb. In addition, co-incubation of untreated tumor cells with supernatants from lethally heat-shocked cells, which contain HSP72, did not lead to HSP72 cell-surface expression. Thus, non-specific association of HSP72 molecules with the outer plasma membrane is unlikely. In conclusion, despite comparable cytoplasmic HSP72 induction, human tumor cells differ from normal cells in their capacity to express HSP72 on their surface. This might imply clinical application as a means to target a stress-inducible, tumor-specific immune response.

Citing Articles

TLR2-Bound Cancer-Secreted Hsp70 Induces MerTK-Mediated Immunosuppression and Tumorigenesis in Solid Tumors.

Kaynak A, Vallabhapurapu S, Davis H, Smith E, Muller P, Vojtesek B Cancers (Basel). 2025; 17(3).

PMID: 39941817 PMC: 11815864. DOI: 10.3390/cancers17030450.


Improved ex vivo fluorescence imaging of human head and neck cancer using the peptide tracer TPP-IRDye800 targeting membrane-bound Hsp70 on tumor cells.

Holzmann K, Wolf J, Stangl S, Lennartz P, Kasajima A, Mogler C Br J Cancer. 2024; 131(11):1814-1824.

PMID: 39406917 PMC: 11589746. DOI: 10.1038/s41416-024-02872-8.


Natural Killer cells at the frontline in the fight against cancer.

Coenon L, Geindreau M, Ghiringhelli F, Villalba M, Bruchard M Cell Death Dis. 2024; 15(8):614.

PMID: 39179536 PMC: 11343846. DOI: 10.1038/s41419-024-06976-0.


Precision USPIO-PEG-SLe Nanotheranostic Agent Targeted Photothermal Therapy for Enhanced Anti-PD-L1 Immunotherapy to Treat Immunotherapy Resistance.

Li T, Guo L, Li J, Mu X, Liu L, Song S Int J Nanomedicine. 2024; 19:1249-1272.

PMID: 38348177 PMC: 10859766. DOI: 10.2147/IJN.S445879.


The Interplay between Heat Shock Proteins and Cancer Pathogenesis: A Novel Strategy for Cancer Therapeutics.

Somu P, Mohanty S, Basavegowda N, Yadav A, Paul S, Baek K Cancers (Basel). 2024; 16(3).

PMID: 38339390 PMC: 10854888. DOI: 10.3390/cancers16030638.